Tempo2 Trial Results and Implications for Minor Stroke Patients

Analysis of the Tempo2 trial comparing tenectaplace with standard care for minor ischemic stroke patients, revealing no significant benefits and highlighting the importance of recognizing stroke symptoms in clinical practice.